. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: Scand Stat Theory Appl. 2015 Jun 5;43(1):103–122. doi: 10.1111/sjos.12167

Table 4.

Predicted CIF of relapse and TRM for a patient who received an HLA-identical sibling donor and allogeneic along transplantation

Unadjusted Weight

Cox model adjusted Weight

1995–2000

2001–2005

1995–2000

2001–2005

Time

{\hat{F}}_{1}

(95% CI)

{\hat{F}}_{2}

(95% CI)

∣ {\hat{F}}_{1} - {\hat{F}}_{2} ∣

{\hat{F}}_{1}

(95% CI)

{\hat{F}}_{2}

(95% CI)

∣ {\hat{F}}_{1} - {\hat{F}}_{2} ∣

RELAPSE

1 Year

0.16 (0.13–0.19)

0.23 (0.18–0.27)

0.07

0.15 (0.13–0.17)

0.24 (0.18–0.30)

0.09

3 Year

0.25 (0.20–0.29)

0.34 (0.28–0.40)

0.09

0.22 (0.20–0.25)

0.35 (0.28–0.42)

0.13

5 Year

0.29 (0.24–0.34)

0.40 (0.33–0.46)

0.11

0.26 (0.24–0.30)

0.41 (0.33–0.49)

0.15

TRM

1 Year

0.38 (0.32–0.43)

0.23 (0.18–0.28)

0.15

0.37 (0.34–0.41)

0.23 (0.17–0.29)

0.14

3 Year

0.42 (0.37–0.48)

0.26 (0.20–0.32)

0.16

0.42 (0.38–0.46)

0.27 (0.20–0.33)

0.15

5 Year

0.44 (0.38–0.49)

0.27 (0.21–0.33)

0.17

0.43 (0.39–0.47)

0.27 (0.21–0.34)

0.16